Retained Earnings (Accumulated Deficit) of BIO-TECHNE Corp from 30 Jun 2010 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
BIO-TECHNE Corp quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 30 Jun 2010 to 31 Dec 2025.
  • BIO-TECHNE Corp Retained Earnings (Accumulated Deficit) for the quarter ending 31 Dec 2025 was $1,106,819,000, a 14% decline year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 $1,106,819,000 -$179,880,000 -14% 31 Dec 2025 10-Q 04 Feb 2026 2026 Q2
Q3 2025 $1,082,534,000 -$258,641,000 -19% 30 Sep 2025 10-Q 05 Nov 2025 2026 Q1
Q2 2025 $1,066,049,000 -$259,198,000 -20% 30 Jun 2025 10-Q 04 Feb 2026 2026 Q2
Q1 2025 $1,196,385,000 -$101,303,000 -7.8% 31 Mar 2025 10-Q 08 May 2025 2025 Q3
Q4 2024 $1,286,699,000 +$25,323,000 +2% 31 Dec 2024 10-Q 06 Feb 2025 2025 Q2
Q3 2024 $1,341,175,000 +$13,603,000 +1% 30 Sep 2024 10-Q 05 Nov 2024 2025 Q1
Q2 2024 $1,325,247,000 +$15,786,000 +1.2% 30 Jun 2024 10-K 22 Aug 2025 2025 FY
Q1 2024 $1,297,688,000 +$51,076,000 +4.1% 31 Mar 2024 10-Q 06 May 2024 2024 Q3
Q4 2023 $1,261,376,000 +$61,400,000 +5.1% 31 Dec 2023 10-Q 07 Feb 2024 2024 Q2
Q3 2023 $1,327,572,000 +$165,057,000 +14% 30 Sep 2023 10-Q 07 Nov 2023 2024 Q1
Q2 2023 $1,309,461,000 +$186,524,000 +17% 30 Jun 2023 10-K 22 Aug 2024 2024 FY
Q1 2023 $1,246,612,000 +$113,805,000 +10% 31 Mar 2023 10-Q 08 May 2023 2023 Q3
Q4 2022 $1,199,976,000 +$54,335,000 +4.7% 31 Dec 2022 10-Q 07 Feb 2023 2023 Q2
Q3 2022 $1,162,515,000 +$43,178,000 +3.9% 30 Sep 2022 10-Q 07 Nov 2022 2023 Q1
Q2 2022 $1,122,937,000 +$37,476,000 +3.5% 30 Jun 2022 10-K 23 Aug 2023 2023 FY
Q1 2022 $1,132,807,000 +$44,019,000 +4% 31 Mar 2022 10-Q 09 May 2022 2022 Q3
Q4 2021 $1,145,641,000 +$40,879,000 +3.7% 31 Dec 2021 10-Q 07 Feb 2022 2022 Q2
Q3 2021 $1,119,337,000 +$45,975,000 +4.3% 30 Sep 2021 10-Q 08 Nov 2021 2022 Q1
Q2 2021 $1,085,461,000 +$27,991,000 +2.6% 30 Jun 2021 10-K 24 Aug 2022 2022 FY
Q1 2021 $1,088,788,000 +$76,075,000 +7.5% 31 Mar 2021 10-Q 07 May 2021 2021 Q3
Q4 2020 $1,104,762,000 +$65,979,000 +6.4% 31 Dec 2020 10-Q 08 Feb 2021 2021 Q2
Q3 2020 $1,073,362,000 +$142,004,000 +15% 30 Sep 2020 10-Q 09 Nov 2020 2021 Q1
Q2 2020 $1,057,470,000 +$125,536,000 +13% 30 Jun 2020 10-K 25 Aug 2021 2021 FY
Q1 2020 $1,012,713,000 +$84,940,000 +9.2% 31 Mar 2020 10-Q 11 May 2020 2020 Q3
Q4 2019 $1,038,783,000 +$143,578,000 +16% 31 Dec 2019 10-Q 06 Feb 2020 2020 Q2
Q3 2019 $931,358,000 +$26,219,000 +2.9% 30 Sep 2019 10-Q 06 Nov 2019 2020 Q1
Q2 2019 $931,934,000 +$55,003,000 +6.3% 30 Jun 2019 10-K 26 Aug 2020 2020 FY
Q1 2019 $927,773,000 +$80,463,000 +9.5% 31 Mar 2019 10-Q 07 May 2019 2019 Q3
Q4 2018 $895,205,000 +$55,641,000 +6.6% 31 Dec 2018 10-Q 07 Feb 2019 2019 Q2
Q3 2018 $905,139,000 +$102,705,000 +13% 30 Sep 2018 10-Q 07 Nov 2018 2019 Q1
Q2 2018 $876,931,000 +$77,904,000 +9.8% 30 Jun 2018 10-K/A 06 Nov 2019 2019 FY
Q1 2018 $847,310,000 +$68,474,000 +8.8% 31 Mar 2018 10-Q 09 May 2018 2018 Q3
Q4 2017 $839,564,000 +$70,559,000 +9.2% 31 Dec 2017 10-Q 08 Feb 2018 2018 Q2
Q3 2017 $802,434,000 +$27,700,000 +3.6% 30 Sep 2017 10-Q 09 Nov 2017 2018 Q1
Q2 2017 $799,027,000 +$28,474,000 +3.7% 30 Jun 2017 10-K 27 Aug 2018 2018 FY
Q1 2017 $778,836,000 +$21,910,000 +2.9% 31 Mar 2017 10-Q 10 May 2017 2017 Q3
Q4 2016 $769,005,000 +$30,467,000 +4.1% 31 Dec 2016 10-Q 09 Feb 2017 2017 Q2
Q3 2016 $774,734,000 +$50,148,000 +6.9% 30 Sep 2016 10-Q 09 Nov 2016 2017 Q1
Q2 2016 $770,553,000 +$56,702,000 +7.9% 30 Jun 2016 10-K 07 Sep 2017 2017 FY
Q1 2016 $756,926,000 +$57,460,000 +8.2% 31 Mar 2016 10-Q 10 May 2016 2016 Q3
Q4 2015 $738,538,000 +$51,478,000 +7.5% 31 Dec 2015 10-Q 09 Feb 2016 2016 Q2
Q3 2015 $724,586,000 +$58,872,000 +8.8% 30 Sep 2015 10-Q 09 Nov 2015 2016 Q1
Q2 2015 $713,851,000 +$60,572,000 +9.3% 30 Jun 2015 10-K 29 Aug 2016 2016 FY
Q1 2015 $699,466,000 +$61,543,000 +9.6% 31 Mar 2015 10-Q 11 May 2015 2015 Q3
Q4 2014 $687,060,000 +$69,338,000 +11% 31 Dec 2014 10-Q 09 Feb 2015 2015 Q2
Q3 2014 $665,714,000 +$61,612,000 +10% 30 Sep 2014 10-Q 10 Nov 2014 2015 Q1
Q2 2014 $653,279,000 +$65,554,000 +11% 30 Jun 2014 10-K 31 Aug 2015 2015 FY
Q1 2014 $637,923,000 +$65,737,000 +11% 31 Mar 2014 10-Q 12 May 2014 2014 Q3
Q4 2013 $617,722,000 +$67,602,000 +12% 31 Dec 2013 10-Q 04 Feb 2014 2014 Q2
Q3 2013 $604,102,000 +$68,297,000 +13% 30 Sep 2013 10-Q 12 Nov 2013 2014 Q1
Q2 2013 $587,725,000 +$67,277,000 +13% 30 Jun 2013 10-K 29 Aug 2014 2014 FY
Q1 2013 $572,186,000 +$66,352,000 +13% 31 Mar 2013 10-Q 10 May 2013 2013 Q3
Q4 2012 $550,120,000 +$62,596,000 +13% 31 Dec 2012 10-Q 11 Feb 2013 2013 Q2
Q3 2012 $535,805,000 +$56,254,000 +12% 30 Sep 2012 10-Q 09 Nov 2012 2013 Q1
Q2 2012 $520,448,000 +$47,718,000 +10% 30 Jun 2012 10-K 29 Aug 2013 2013 FY
Q1 2012 $505,834,000 +$51,406,000 +11% 31 Mar 2012 10-Q 10 May 2012 2012 Q3
Q4 2011 $487,524,000 +$54,137,000 +12% 31 Dec 2011 10-Q 07 Feb 2012 2012 Q2
Q3 2011 $479,551,000 +$62,688,000 +15% 30 Sep 2011 10-Q 09 Nov 2011 2012 Q1
Q2 2011 $472,730,000 +$72,611,000 +18% 30 Jun 2011 10-K 29 Aug 2012 2012 FY
Q1 2011 $454,428,000 31 Mar 2011 10-Q 10 May 2011 2011 Q3
Q4 2010 $433,387,000 31 Dec 2010 10-Q 09 Feb 2011 2011 Q2
Q3 2010 $416,863,000 30 Sep 2010 10-Q 09 Nov 2010 2011 Q1
Q2 2010 $400,119,000 30 Jun 2010 10-K 29 Aug 2011 2011 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.